WA HB2710 | 2019-2020 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 5-0)
Status: Engrossed on February 17 2020 - 50% progression, died in committee
Action: 2020-03-12 - By resolution, returned to House Rules Committee for third reading.
Pending: Senate Rules Committee
Text: Latest bill text (Introduced) [PDF]
Status: Engrossed on February 17 2020 - 50% progression, died in committee
Action: 2020-03-12 - By resolution, returned to House Rules Committee for third reading.
Pending: Senate Rules Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data.
Title
Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data.
Sponsors
Sen. June Robinson [D] | Rep. Gael Tarleton [D] | Rep. Eileen Cody [D] | Rep. Steve Tharinger [D] |
Rep. Timm Ormsby [D] |
Roll Calls
2020-02-17 - House - House 3rd Reading & Final Passage (Y: 56 N: 42 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2020-03-12 | Senate | By resolution, returned to House Rules Committee for third reading. |
2020-02-28 | Senate | Public hearing and executive session scheduled, but no action was taken in the Senate Committee on Health & Long Term Care at 8:00 AM. |
2020-02-19 | Senate | First reading, referred to Health & Long Term Care. |
2020-02-17 | House | Third reading, passed; yeas, 56; nays, 42; absent, 0; excused, 0. |
2020-02-17 | House | Rules suspended. Placed on Third Reading. |
2020-02-16 | House | Rules Committee relieved of further consideration. Placed on second reading. |
2020-02-06 | House | Referred to Rules 2 Review. |
2020-02-04 | House | HCW - Majority; do pass. |
2020-02-04 | House | Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM. |
2020-01-29 | House | Public hearing in the House Committee on Health Care & Wellness at 1:30 PM. |
2020-01-20 | House | First reading, referred to Health Care & Wellness. |